Bank Of America Corp Unity Biotechnology, Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.4 - $4.27 $34,724 - $370,687	-86,812 Reduced 99.91%	76 $0
Q2 2022 Aug 12, 2022	BUY	$0.56 - $1.29 $48,554 - $111,849	86,705 Added 47379.78%	86,888 $48,000
Q1 2022 May 16, 2022	SELL	$0.72 - $1.86 $25,829 - $66,725	-35,874 Reduced 99.49%	183 $0
Q4 2021 Feb 08, 2022	SELL	$1.3 - $3.17 $104,806 - $255,565	-80,620 Reduced 69.1%	36,057 $53,000
Q3 2021 Nov 15, 2021	BUY	$2.91 - $4.5 $97,837 - $151,294	33,621 Added 40.48%	116,677 $350,000
Q2 2021 Sep 13, 2021	BUY	$4.15 - $6.3 $344,682 - $523,252	83,056 New	83,056 $385,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $16.1M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.